682
Participants
Start Date
April 30, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Desvenlafaxine Succinate Sustained-Release 10mg
10 mg tablet, once daily dosing for 8 weeks
Desvenlafaxine Succinate Sustained-Release 50 mg
50 mg tablet, once daily dosing for 8 weeks
placebo
Matching placebo tablets (10 or 50mg). Daily dosing for 10 +/- 4 days during a placebo lead-in period, and then 8 weeks during the double-blind period.
Pfizer Investigational Site, New York
Pfizer Investigational Site, Staten Island
Pfizer Investigational Site, Media
Pfizer Investigational Site, Herndon
Pfizer Investigational Site, Midlothian
Pfizer Investigational Site, Maitland
Pfizer Investigational Site, South Miami
Pfizer Investigational Site, North Miami
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, Toledo
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Waukesha
Pfizer Investigational Site, Middleton
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Denver
Pfizer Investigational Site, Encino
Pfizer Investigational Site, Upland
Pfizer Investigational Site, Redlands
Pfizer Investigational Site, Newport Beach
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Salem
Pfizer Investigational Site, Eugene
Pfizer Investigational Site, Cromwell
Collaborators (1)
Pfizer
INDUSTRY
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY